UniProt ID | E2F6_HUMAN | |
---|---|---|
UniProt AC | O75461 | |
Protein Name | Transcription factor E2F6 | |
Gene Name | E2F6 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 281 | |
Subcellular Localization | Nucleus. | |
Protein Description | Inhibitor of E2F-dependent transcription. Binds DNA cooperatively with DP proteins through the E2 recognition site, 5'-TTTC[CG]CGC-3'. Has a preference for the 5'-TTTCCCGC-3' E2F recognition site. E2F6 lacks the transcriptional activation and pocket protein binding domains. Appears to regulate a subset of E2F-dependent genes whose products are required for entry into the cell cycle but not for normal cell cycle progression. May silence expression via the recruitment of a chromatin remodeling complex containing histone H3-K9 methyltransferase activity. Overexpression delays the exit of cells from the S-phase.. | |
Protein Sequence | MSQQRPARKLPSLLLDPTEETVRRRCRDPINVEGLLPSKIRINLEDNVQYVSMRKALKVKRPRFDVSLVYLTRKFMDLVRSAPGGILDLNKVATKLGVRKRRVYDITNVLDGIDLVEKKSKNHIRWIGSDLSNFGAVPQQKKLQEELSDLSAMEDALDELIKDCAQQLFELTDDKENERLAYVTYQDIHSIQAFHEQIVIAVKAPAETRLDVPAPREDSITVHIRSTNGPIDVYLCEVEQGQTSNKRSEGVGTSSSESTHPEGPEEEENPQQSEELLEVSN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
9 | Sumoylation | SQQRPARKLPSLLLD CCCCCCCCCCHHHCC | 67.85 | 28112733 | |
9 | Ubiquitination | SQQRPARKLPSLLLD CCCCCCCCCCHHHCC | 67.85 | - | |
12 | Phosphorylation | RPARKLPSLLLDPTE CCCCCCCHHHCCCCH | 41.93 | - | |
21 | Phosphorylation | LLDPTEETVRRRCRD HCCCCHHHHHHHCCC | 17.06 | 24719451 | |
38 | Phosphorylation | NVEGLLPSKIRINLE CCCCCCCCCEEEECC | 40.46 | 24719451 | |
43 (in isoform 2) | Ubiquitination | - | 27.77 | - | |
50 | Phosphorylation | NLEDNVQYVSMRKAL ECCCCEEEEEHHHHH | 7.10 | 28796482 | |
52 | Phosphorylation | EDNVQYVSMRKALKV CCCEEEEEHHHHHCC | 14.13 | 28796482 | |
66 (in isoform 2) | Ubiquitination | - | 4.36 | - | |
74 | Acetylation | SLVYLTRKFMDLVRS EEHHHHHHHHHHHHH | 39.54 | 7303075 | |
86 (in isoform 2) | Ubiquitination | - | 3.16 | 21906983 | |
91 | Acetylation | GGILDLNKVATKLGV CCCCCHHHHHHHHCC | 40.31 | 7298809 | |
95 | Ubiquitination | DLNKVATKLGVRKRR CHHHHHHHHCCCCCC | 33.24 | - | |
95 | Acetylation | DLNKVATKLGVRKRR CHHHHHHHHCCCCCC | 33.24 | 7298819 | |
100 | Acetylation | ATKLGVRKRRVYDIT HHHHCCCCCCEEEHH | 41.99 | 7298829 | |
109 | Ubiquitination | RVYDITNVLDGIDLV CEEEHHHHCCCCCCH | 3.74 | - | |
109 (in isoform 2) | Ubiquitination | - | 3.74 | 21906983 | |
110 | Ubiquitination | VYDITNVLDGIDLVE EEEHHHHCCCCCCHH | 5.61 | - | |
118 | Ubiquitination | DGIDLVEKKSKNHIR CCCCCHHHHCCCCEE | 55.67 | 21906983 | |
118 (in isoform 1) | Ubiquitination | - | 55.67 | 21906983 | |
119 | Ubiquitination | GIDLVEKKSKNHIRW CCCCHHHHCCCCEEE | 53.83 | - | |
141 | Ubiquitination | FGAVPQQKKLQEELS CCCCCCHHHHHHHHH | 50.64 | 2190698 | |
141 (in isoform 1) | Ubiquitination | - | 50.64 | 21906983 | |
142 | Ubiquitination | GAVPQQKKLQEELSD CCCCCHHHHHHHHHH | 51.57 | - | |
175 | Ubiquitination | LFELTDDKENERLAY HHHHCCCCCCCEEEE | 66.31 | - | |
221 | Phosphorylation | APREDSITVHIRSTN CCCCCEEEEEEEECC | 15.24 | 22985185 | |
226 | Phosphorylation | SITVHIRSTNGPIDV EEEEEEEECCCCEEE | 26.14 | - | |
243 | Phosphorylation | CEVEQGQTSNKRSEG EEECCCCCCCCCCCC | 40.88 | - | |
280 | Phosphorylation | SEELLEVSN------ HHHHHHHCC------ | 27.70 | 28509920 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of E2F6_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of E2F6_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...